Blastomyces dermatitidis Antibodies by EIA with Reflex to Immunodiffusion, Serum
Also known as: Blastomyces Total antibodies
Use
Diagnosis of Blastomycosis relies on a combination of assays, including culture and molecular testing on appropriate specimens and serologic evaluation for both antibodies to and antigen released from Blastomyces. Although culture remains the gold standard method and is highly specific, the organism can take several days to weeks to grow, and sensitivity is diminished in cases of acute or localized disease. Similarily, molecular testing offers high specificity and a rapid turnaround time, however, sensitivity is imperfect. Detection of an antibody response to Blastomyces offers high specificity, however, results may be falsely negative in acutely infected patients and in immunosuppressed patients.
Special Instructions
If Blastomyces antibodies are equivocal or positive by EIA, then Blastomyces Antibodies, Quantitative, DID [164293] will be added at an additional charge.
Limitations
The test has limitations, including possible false negatives in cases of acute or localized infection and in immunosuppressed patients. Culture, while the gold standard, can be slow and has reduced sensitivity in certain cases. Molecular testing, while faster and specific, also does not have perfect sensitivity. Negative serology does not exclude infection.
Methodology
Immunoassay (EIA)
Biomarkers
LOINC Codes
- 7816-2
- 7816-2
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.0 mL
Minimum Volume
0.5 mL
Container
Gel-barrier tube, serum from a gel-barrier tube, serum from a red-top tube, serum transfer tube
Causes for Rejection
Gross hemolysis; grossly lipemic
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
